IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $7,805,000 | +2.0% | 401,265 | -12.7% | 0.02% | 0.0% |
Q4 2017 | $7,650,000 | -37.4% | 459,465 | -23.7% | 0.02% | -40.0% |
Q3 2017 | $12,228,000 | -20.5% | 602,365 | -37.0% | 0.04% | -31.4% |
Q2 2017 | $15,387,000 | +11.1% | 955,727 | -12.7% | 0.05% | +13.3% |
Q1 2017 | $13,850,000 | -0.6% | 1,094,829 | +4.1% | 0.04% | -15.1% |
Q4 2016 | $13,930,000 | +148.0% | 1,051,318 | +343.7% | 0.05% | +120.8% |
Q3 2016 | $5,616,000 | +3.6% | 236,949 | +26.0% | 0.02% | -14.3% |
Q2 2016 | $5,420,000 | -3.6% | 188,049 | +7.1% | 0.03% | -9.7% |
Q1 2016 | $5,624,000 | -18.6% | 175,649 | +8.7% | 0.03% | -24.4% |
Q4 2015 | $6,909,000 | +1808.6% | 161,578 | +1524.1% | 0.04% | +1950.0% |
Q3 2015 | $362,000 | -85.0% | 9,949 | -81.0% | 0.00% | -89.5% |
Q2 2015 | $2,408,000 | +16.1% | 52,449 | +18.5% | 0.02% | +18.8% |
Q1 2015 | $2,074,000 | +12.0% | 44,249 | -24.3% | 0.02% | +6.7% |
Q4 2014 | $1,852,000 | -51.4% | 58,449 | -63.7% | 0.02% | -50.0% |
Q3 2014 | $3,814,000 | -34.4% | 160,849 | -17.0% | 0.03% | -33.3% |
Q2 2014 | $5,811,000 | -19.8% | 193,749 | -29.4% | 0.04% | -31.8% |
Q1 2014 | $7,248,000 | +6.3% | 274,349 | +1.2% | 0.07% | 0.0% |
Q4 2013 | $6,816,000 | +168.7% | 271,049 | +119.0% | 0.07% | +120.0% |
Q3 2013 | $2,537,000 | – | 123,749 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |